FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

70562007: Leuprorelin acetate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
117207019 Leuprolide acetate en Synonym Active Entire term case insensitive SNOMED CT core module
117208012 Leuprorelin acetate en Synonym Active Entire term case insensitive SNOMED CT core module
3720080013 Leuprorelin acetate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Leuprorelin acetate Is a Acetate false Inferred relationship Existential restriction modifier
Leuprorelin acetate Is a Medicinal product acting as antineoplastic agent (product) false Inferred relationship Existential restriction modifier
Leuprorelin acetate Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Leuprorelin acetate Is a Leuprorelin false Inferred relationship Existential restriction modifier
Leuprorelin acetate Is a Acetate compound false Inferred relationship Existential restriction modifier
Leuprorelin acetate Has disposition Hypothalamic releasing factor true Inferred relationship Existential restriction modifier
Leuprorelin acetate Is modification of Leuprorelin true Inferred relationship Existential restriction modifier
Leuprorelin acetate Is a Gonad regulating hormone agent true Inferred relationship Existential restriction modifier
Leuprorelin acetate Is a Gonadotropin releasing factor true Inferred relationship Existential restriction modifier
Leuprorelin acetate Is a Hypothalamic releasing factor false Inferred relationship Existential restriction modifier
Leuprorelin acetate Has disposition Gonad regulating hormone true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Mawdsley-Brooks & Company Ltd) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Mawdsley-Brooks & Company Ltd) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Mawdsley-Brooks & Company Ltd) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Necessity Supplies Ltd) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Necessity Supplies Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Necessity Supplies Ltd) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Necessity Supplies Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Necessity Supplies Ltd) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Necessity Supplies Ltd) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 11.25mg powder and solvent for suspension for injection pre-filled syringes Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 3.75mg powder and solvent for suspension for injection pre-filled syringes Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR DCS 3.75mg powder and solvent for suspension for injection pre-filled syringes (Takeda UK Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes (Takeda UK Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 11.25mg powder and solvent for suspension for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 3.75mg powder and solvent for suspension for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR DCS 3.75mg powder and solvent for suspension for injection pre-filled syringes (Takeda UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes (Takeda UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 11.25mg powder and solvent for suspension for injection pre-filled syringes Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 3.75mg powder and solvent for suspension for injection pre-filled syringes Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR DCS 3.75mg powder and solvent for suspension for injection pre-filled syringes (Takeda UK Ltd) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes (Takeda UK Ltd) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes (Doncaster Pharmaceuticals Ltd) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes (Doncaster Pharmaceuticals Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR DCS 3.75mg powder and solvent for suspension for injection pre-filled syringes (Doncaster Pharmaceuticals Ltd) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR DCS 3.75mg powder and solvent for suspension for injection pre-filled syringes (Doncaster Pharmaceuticals Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes (Doncaster Pharmaceuticals Ltd) 1 pre-filled disposable injection Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR DCS 3.75mg powder and solvent for suspension for injection pre-filled syringes (Doncaster Pharmaceuticals Ltd) 1 pre-filled disposable injection Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 22.5mg powder and solvent for suspension for injection vials Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Lutrate 3 month Depot 22.5mg powder and solvent for suspension for injection vials (AMCo) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Lutrate 1 month Depot 3.75mg powder and solvent for suspension for injection vials (AMCo) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Lutrate 1 month Depot 3.75mg powder and solvent for suspension for injection vials (AMCo) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 22.5mg powder and solvent for suspension for injection vials 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Lutrate 3 month Depot 22.5mg powder and solvent for suspension for injection vials (AMCo) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Lutrate 1 month Depot 3.75mg powder and solvent for suspension for injection vials (AMCo) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 3.75mg powder and solvent for suspension for injection vials Has specific active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 11.25mg powder and solvent for suspension for injection vials Has specific active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 11.25mg powder and solvent for suspension for injection vials Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 3.75mg powder and solvent for suspension for injection vials Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes (Originalis B.V.) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes (Originalis B.V.) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes (Originalis B.V.) 1 pre-filled disposable injection Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier

Start Page 2 of 2


This concept is not in any reference sets

Back to Start